Chronic kidney disease results in deficiency of ABCC6, the novel inhibitor of vascular calcification

American Journal of Nephrology

Volumn 40, Issue 1, 2014, Pages 51-55

  Lau, Wei Ling ^a   Liu, Shuman ^a   Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ABCC6; Cardiovascular disease; Chronic kidney disease

Indexed keywords

MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 6; CALCIUM; FETUIN A; PHOSPHATE; ABC TRANSPORTER; ABCC6 PROTEIN, MOUSE; AHSG PROTEIN, MOUSE; AHSG PROTEIN, RAT; MRP6 PROTEIN, RAT; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIET; INTERSTITIAL NEPHRITIS; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; RNA ANALYSIS; SOFT TISSUE CALCIFICATION; ABCC6 GENE; ARTERY CALCIFICATION; CALCIUM HOMEOSTASIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HYPERTENSION; INFLAMMATION; MOUSE; MUTATOR GENE; PHOSPHATE METABOLISM; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSEUDOXANTHOMA ELASTICUM; RNA TRANSCRIPTION; ANIMAL; CHRONIC KIDNEY FAILURE; DBA MOUSE; GENETICS; KIDNEY; LIVER; METABOLISM; SPRAGUE DAWLEY RAT;

ALPHA-2-HS-GLYCOPROTEIN; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; KIDNEY; LIVER; MALE; MICE; MICE, INBRED DBA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; VASCULAR CALCIFICATION;

EID: 84928348463     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000365014     Document Type: Article

References (37)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065
2. Giachelli CM: The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-897
3. Moe S, Chen N: Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008; 19: 213-216
4. Lau WL, Ix JH: Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcification: A pattern of vascular injury associated with aberrant mineral metabolism. Semin Nephrol 2013; 33: 93-105
5. Olauson H, Larsson TE: FGF23 and Klotho in chronic kidney disease. Curr Opin Nephrol Hypertens 2013; 22: 397-404
6. Miksch S, Lumsden A, Guenther UP, Foernzler D, Christen-Zach S, Daugherty C, et al: Molecular genetics of pseudoxanthoma elasticum: Type and frequency of mutations in ABCC6. Hum Mutat 2005; 26: 235-248
7. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, et al: Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000; 25: 228-231
8. Kool M, Van Der Linden M, De Haas M, Baas F, Borst P: Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 1999; 59: 175-182
9. Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A: Pseudoxanthoma elasticum: A clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 2005; 42: 881-892
10. Uitto J, Bercovitch L, Terry SF, Terry PF: Pseudoxanthoma elasticum: Progress in diagnostics and research towards treatment: Summary of the 2010 PXE International Research Meeting. Am J Med Genet A 2011; 155A:1517-1526
11. Korff S, Schoensiegel F, Riechert N, Weichenhan D, Katus HA, Ivandic BT: Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. Physiol Genomics 2006; 25: 387-392
12. Meng H, Vera I, Che N, Wang X, Wang SS, Ingram-Drake L, et al: Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci USA 2007; 104: 4530-4535
13. Wang SS, Martin LJ, Schadt EE, Meng H, Wang X, Zhao W, et al: Disruption of the aortic elastic lamina and medial calcification share genetic determinants in mice. Circ Cardiovasc Genet 2009; 2: 573-582
14. Shroff R, McNair R, Figg N, Skepper J, Schurgers L, Gupta A, et al: Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757
15. Meng H, Vera I, Che N, Wang X, Wang SS, Ingram-Drake L, et al: Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci USA 2007; 104: 4530-4535
16. Shao J, Cheng S, Pingsterhaus J, Charlton-Kachigian N, Loewy A, Towler D: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005; 115: 1210-1220
17. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, Heistad DD: Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 2008; 52: 843-850
18. Li Q, Jiang Q, Pfendner E, Varadi A, Uitto J: Pseudoxanthoma elasticum: Clinical phenotypes, molecular genetics and putative pathomechanisms. Exp Dermatol 2009; 18: 1-11
19. Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Gotting C: Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 2006; 52: 227-234
20. Jiang Q, Dibra F, Lee MD, Oldenburg R, Uitto J: Overexpression of fetuin-A counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (ABCC6-/-). J Invest Dermatol 2010; 130: 1288-1296
21. Vanakker OM, Martin L, Gheduzzi D, Leroy BP, Loeys BL, Guerci VI, et al: Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007; 127: 581-587
22. Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, et al: Fibroblast growth factor 23 and fetuin-A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1780-1786
23. Blaha V, Mistrik E, Dusilova-Sulkova S, Kalousova M, Andrys C, Blaha M, et al: Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin Biochem 2009; 42: 996-1000
24. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 2003; 361: 827-833
25. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, et al: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005; 67: 2295-2304
26. Koos R, Krueger T, Westenfeld R, Kuhl H, Brandenburg V, Mahnken A, et al: Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009; 101: 706-713
27. Schlieper G, Westenfeld R, Kruger T, Cranenburg EC, Magdeleyns EJ, Brandenburg VM, et al: Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011; 22: 387-395
28. Jansen RS, Kucukosmanoglu A, De Haas M, Sapthu S, Otero JA, Hegman IE, et al: ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci USA 2013; 110: 20206-20211
29. Baccarani-Contri M, Vincenzi D, Cicchetti F, Mori G, Pasquali-Ronchetti I: Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients. Eur J Histochem 1994; 38: 111-123
30. Gotting C, Adam A, Szliska C, Kleesiek K: Circulating P-, L-And E-selectins in pseudoxanthoma elasticum patients. Clin Biochem 2008; 41: 368-374
31. Diekmann U, Zarbock R, Hendig D, Szliska C, Kleesiek K, Gotting C: Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med (Berl) 2009; 87: 965-970
32. Amann K, Wolf B, Nichols C, Tornig J, Schwarz U, Zeier M, et al: Aortic changes in experimental renal failure: Hyperplasia or hypertrophy of smooth muscle cells?. Hypertension 1997; 29: 770-775
33. Pai A, Leaf EM, El-Abbadi M, Giachelli CM: Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol 2011; 178: 764-773
34. Ibels L, Alfrey A, Huffer W, Craswell P, Anderson J, Weil RR: Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979; 66: 790-796
35. Chung A, Yang H, Kim J, Sigrist M, Chum E, Gourlay W, et al: Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 2009; 120: 792-801
36. Rutsch F, Nitschke Y, Terkeltaub R: Genetics in arterial calcification: Pieces of a puzzle and cogs in a wheel. Circ Res 2011; 109: 578-592
37. Ilias A, Urban Z, Seidl TL, Le Saux O, Sinko E, Boyd CD, et al: Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-Associated mutants of human ABCC6 (MRP6). J Biol Chem 2002; 277: 16860-16867